Suchergebnisse - "Talamonti, Marina"

PubPharm (6)

1

HLA-Cw6 and other HLA-C alleles, as well as MICB-DT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis

enthalten in: Expert opinion on biological therapy | 2021

von Morelli, M. | Galluzzo, M. | Madonna, S. | +9

2

Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy

enthalten in: Molecular diagnosis & therapy | 2018

von Galluzzo, M. | D'Adamio, S. | Campione, E. | +2

3

HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients : A Retrospective Cohort Study

enthalten in: Molecular diagnosis & therapy | 2017

von Talamonti, M. | Galluzzo, M. | Zangrilli, A. | +6

4

HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis : Outcome and long-term follow-up

enthalten in: Journal of the American Academy of Dermatology | 2016

von Talamonti, M. | Galluzzo, M. | Chimenti, S. | +1

5

IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis

enthalten in: Dermatology (Basel, Switzerland) | 2016

von Galluzzo, M. | Boca, A. | Botti, E. | +8

6

Genetic variations in IL6 and IL12B decreasing the risk for psoriasis

enthalten in: Immunology letters | 2013

von Boca, A. | Talamonti, M. | Galluzzo, M. | +5

1
[1]